Quantum Diamond Technologies

Building a quantum sensor capability with the potential to disrupt the biomarker detection and medical diagnostics fields.

New quantum technologies are coming online at an accelerating pace after years of intensive research. Powered by the fundamental properties of quantum mechanics, these systems will revolutionize the ways we process and transmit information, and allow us to make faster and more precise measurements about the world around us.

Based on world-leading research at Harvard University, QDTI is exploiting quantum systems engineered into diamond crystal – called nitrogen vacancy (NV) centers. These NV centers are the engine that will power the novel approach to biomolecule detection.

simple.

fast.

quantum.

 

Quantum Diamond Technologies

Building a quantum sensor capability with the potential to disrupt the biomarker detection and medical diagnostics fields.

New quantum technologies are coming online at an accelerating pace after years of intensive research. Powered by the fundamental properties of quantum mechanics, these systems will revolutionize the ways we process and transmit information, and allow us to make faster and more precise measurements about the world around us.

Based on world-leading research at Harvard University, QDTI is exploiting quantum systems engineered into diamond crystal – called nitrogen vacancy (NV) centers. These NV centers are the engine that will power the novel approach to biomolecule detection.








simple.

fast.

quantum.

QDTI Imaging Technology

NV centers are tiny defects in the diamond crystal whose electronic states measure the local environment with very high sensitivity and spatial resolution. To make the imaging platform, QDTI uses billions of NV centers just below the surface of a synthetic diamond sensor. The quantum-doped sensor can rapidly image magnetic fields from objects as small as a few nanometers. The NV imager acts like a magnetic microscope – making detailed images of magnetic fields instead of light – with unrivaled sensitivity and throughput.

QDTI is leveraging this versatile NV magnetic imaging technology to create a novel, ultrasensitive biomaterial detection and diagnostics platform.

Magnetic-based Immunoassay Detection

Current immunoassays diagnostics rely on optical detection technologies.  Due to significant optical background in biological samples, these optical platforms are costly, time consuming and cumbersome due to the extensive sample washing and preparation needed.

  The QDTI imaging platform – using magnetic versus optical tags – enables an extremely simple, reliable and high-performance diagnostic capability.  This all-magnetic detection approach is simpler, cheaper and highly flexible, allowing new biomarkers to be targeted quickly in key areas like neurology (such Alzheimer’s Disease and Parkinson’s), immuno-oncology and infectious disease.

The QDTI magnetic detection approach holds tremendous potential to improve detection of critical biomarkers (e.g. proteins, nucleic acids, cells) with impacts on all phases of biomedical research and patient care.

Why QDTI?




Ultra Simple Sample Preparation
The QDTI magnetic assay requires minimal sample processing before it is measured. Many existing systems have a large number of steps that require technician time before the test can be performed.



Ultrasensitive Detection of Low-concentration Biomarkers
In addition to dramatically reduced sample prep and sample input needs, the QDTI system can deliver ultrasensitive performance without the attendant complexity and costs. This capability offers new diagnostic tools for improved clinical decisions and better patient health.


Minimal Sample Input
Since the sample is not being repeatedly washed before reading, there is little loss of material. The QDTI diagnostic protocol requires only a few microliters of sample to perform the assay – a critical benefit when sample availability is limited.


Flexibility in Biomarker Targets
QDTI is building an open platform right from the start. Users will be able to use the QDTI technology platform to build their own assays for their own drug discovery, companion diagnostics, or other application needs. In addition to proteins, the QDTI system will also be able to provide detection for nucleic acids and cells – all on the same detection platform.

Meet the Team

CORE TEAM

Colin Connolly

Director
Technology Development


Jeff Randall

Director
Assay Technologies


Tomasz Piech

Director
Software Engineering


Akim Lennhoff

Director
Engineering


 

John Pena

Chief Executive Officer


Seabron Adamson

Chief Financial Officer


 
 

ADVISORY BOARD
 
 

Contact Us

Quantum Diamond Technologies Inc.
28 Dane Street Somerville,
MA 02143

info@quantumdiamondtech.com
 

Careers

Buy now